IceCure Medical (ICCM) Expected to Announce Earnings on Thursday

IceCure Medical (NASDAQ:ICCM) is expected to issue its quarterly earnings data before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $1.07 million for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.

IceCure Medical Price Performance

IceCure Medical stock opened at $1.29 on Tuesday. IceCure Medical has a one year low of $0.48 and a one year high of $1.66. The business has a fifty day moving average price of $1.32 and a 200-day moving average price of $0.98. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.67 and a quick ratio of 2.27. The firm has a market capitalization of $71.60 million, a P/E ratio of -4.45 and a beta of 0.37.

Wall Street Analyst Weigh In

Separately, HC Wainwright reissued a “buy” rating and issued a $2.50 target price on shares of IceCure Medical in a research note on Wednesday, November 27th.

IceCure Medical Company Profile

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.